Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-Blockers in Allergic Rhinitis
NCT01946035Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Sep 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in allergic rhinitis (AR) comparing Doxazosin XL with Placebo (2 arms). Primary endpoint: Peak Nasal Inspiratory Flow. Started Sep 2013; status: completed.
02
Drugs
doxazosin
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01946035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01946035.